Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)

China flag China · Delayed Price · Currency is CNY
59.87
-0.37 (-0.61%)
Aug 14, 2025, 2:45 PM CST
-0.61%
Market Cap66.02B
Revenue (ttm)3.86B
Net Income (ttm)350.11M
Shares Out1.11B
EPS (ttm)0.31
PE Ratio192.76
Forward PE120.65
Dividend0.42 (0.69%)
Ex-Dividend DateMay 15, 2025
Volume6,067,749
Average Volume4,743,400
Open56.35
Previous Close60.24
Day's Range56.35 - 60.96
52-Week Range27.50 - 62.65
Beta-0.15
RSI67.37
Earnings DateAug 23, 2025

About SHE:002653

Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products in China. The company offers anesthetic analgesic, neuropsychiatric system, and digestive liver and parenteral nutrition medications; drugs for the endocrine and cardiovascular system; oncology-related drugs; andrology drugs; desonide and liprocaine cream; propofol medium/long chain fat emulsion and hydroxyethyl starch sodium chloride injection; sodium fusidicate ointment; lupatadine fumarate tablets; and caspofungin acetate and methylpre... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 5,337
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002653
Full Company Profile

Financial Performance

In 2024, SHE:002653's revenue was 3.72 billion, an increase of 10.92% compared to the previous year's 3.36 billion. Earnings were 395.46 million, an increase of 34.00%.

Financial Statements

News

There is no news available yet.